| Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis | Journal of Clinical Endocrinology and Metabolism | 2009 | 445 |
| The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society | Atherosclerosis | 2015 | 420 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Archives of Medical Science | 2015 | 252 |
| Non-alcoholic fatty liver disease and dyslipidemia: An update | Metabolism: Clinical and Experimental | 2016 | 212 |
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Nutrition Reviews | 2017 | 186 |
| Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation | Nutrition Reviews | 2017 | 183 |
| The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio | Clinical and Applied Thrombosis/Hemostasis | 2016 | 176 |
| Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Archives of Medical Science | 2017 | 173 |
| Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study | Journal of Psychosomatic Research | 2010 | 168 |
| Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? | Progress in Lipid Research | 2012 | 160 |
| The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology | 2018 | 157 |
| Multiple actions of high-density lipoprotein | Current Opinion in Cardiology | 2008 | 154 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement | Metabolism: Clinical and Experimental | 2017 | 152 |
| The role of Toll-like receptors in renal diseases | Nature Reviews Nephrology | 2010 | 145 |
| Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Journal of the American Heart Association | 2016 | 141 |
| Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials | Mayo Clinic Proceedings | 2015 | 139 |
| Socio-economic status is associated with epigenetic differences in the pSoBid cohort | International Journal of Epidemiology | 2012 | 139 |
| Lipid-modifying effects of nutraceuticals: An evidence-based approach | Nutrition | 2016 | 133 |
| Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients | International Journal of Cardiology | 2015 | 129 |
| "Is obesity linked to aging?": adipose tissue and the role of telomeres | Ageing Research Reviews | 2012 | 127 |
| Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies | BMC Medicine | 2015 | 126 |
| Endocan: A novel inflammatory indicator in cardiovascular disease? | Atherosclerosis | 2015 | 123 |
| Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? | Osteoporosis International | 2009 | 117 |
| Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms | Atherosclerosis | 2016 | 117 |
| Leptin, cardiovascular diseases and type 2 diabetes mellitus | Acta Pharmacologica Sinica | 2018 | 112 |
